120 related articles for article (PubMed ID: 7367833)
1. Serum selenium levels in malignant lymphoproliferative diseases.
Calautti P; Moschini G; Stievano BM; Tomio L; Calzavara F; Perona G
Scand J Haematol; 1980 Jan; 24(1):63-6. PubMed ID: 7367833
[TBL] [Abstract][Full Text] [Related]
2. Serum selenium levels in untreated children with acute lymphoblastic leukemia. I.
Mikac-Dević M; Ferenec D; Tiefenbach A
J Trace Elem Electrolytes Health Dis; 1990 Mar; 4(1):7-10. PubMed ID: 2135960
[TBL] [Abstract][Full Text] [Related]
3. [Beta 2 microglobulin].
Clément F
Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
[TBL] [Abstract][Full Text] [Related]
4. Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies.
Avanzini P; Vinceti M; Ilariucci F; Masini L; D'Incà M; Vivoli G
Haematologica; 1995; 80(6):505-11. PubMed ID: 8647514
[TBL] [Abstract][Full Text] [Related]
5. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases.
Child JA; Kushwaha MR
Hematol Oncol; 1984; 2(4):391-401. PubMed ID: 6396193
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
8. Zinc and selenium status in pediatric malignant lymphomas.
Cavdar AO; Gözdaşoğlu S; Babacan E; Mengübaş K; Unal E; Yavuz G; Taçyildiz N
Nutr Cancer; 2009; 61(6):888-90. PubMed ID: 20155631
[TBL] [Abstract][Full Text] [Related]
9. Serum beta 2-microglobulin in malignant lymphoproliferative disorders.
Melillo L; Musto P; Tomasi P; Cascavilla N; Bodenizza C; Ladogana S; Carotenuto M
Tumori; 1988 Apr; 74(2):129-35. PubMed ID: 3285553
[TBL] [Abstract][Full Text] [Related]
10. Serum selenium and reticuloendothelial tumors.
Broghamer WL; McConnell KP; Grimaldi M; Blotcky AJ
Cancer; 1978 Apr; 41(4):1462-6. PubMed ID: 639004
[TBL] [Abstract][Full Text] [Related]
11. [Serumferritin in patients with malignant lymphomas (author's transl)].
Oertel J; Schultz E; Korinth E; Heilhecker A
Klin Wochenschr; 1977 Nov; 55(22):1109-14. PubMed ID: 592680
[TBL] [Abstract][Full Text] [Related]
12. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
[TBL] [Abstract][Full Text] [Related]
13. Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia.
Kornberg A; Polliack A
Blood; 1980 Sep; 56(3):351-5. PubMed ID: 6931618
[TBL] [Abstract][Full Text] [Related]
14. Serum ferritin in Nigerian patients with Burkitt's lymphoma and other malignant diseases.
Bolarin DM
Acta Trop; 1983 Mar; 40(1):71-7. PubMed ID: 6134456
[TBL] [Abstract][Full Text] [Related]
15. Relation of bone marrow findings to serum protein changes in lymphosarcoma, chronic lymphocytic leukemia and Hodgkin's disease.
ONAT A; COOPER T
Blood; 1960 Jan; 15():114-29. PubMed ID: 14428869
[No Abstract] [Full Text] [Related]
16. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.
Idilman R; Bozkus Y; Seval G; Mizrak D; Cinar K; Ustun Y; Bektas M; Arat M; Akbulut H; Doganay B; Ozden A
J Med Virol; 2011 Jun; 83(6):974-80. PubMed ID: 21503909
[TBL] [Abstract][Full Text] [Related]
17. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
[No Abstract] [Full Text] [Related]
18. [Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders].
Kłoczko J; Zuch A; Bielawiec M; Buluk K
Acta Haematol Pol; 1983; 14(1):13-9. PubMed ID: 6577768
[No Abstract] [Full Text] [Related]
19. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
Last KW; Cornelius V; Delves T; Sieniawska C; Fitzgibbon J; Norton A; Amess J; Wilson A; Rohatiner AZ; Lister TA
J Clin Oncol; 2003 Jun; 21(12):2335-41. PubMed ID: 12805335
[TBL] [Abstract][Full Text] [Related]
20. [Reaction of the system of specific cortisol transport to a hemoblastosis process].
Goncharova ND; Goncharov NP; Lebedev VN
Biull Eksp Biol Med; 1986 Mar; 101(3):344-6. PubMed ID: 3456803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
